BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Foundation for Sarcoidosis Research (FSR) receives confirmation from the Department of Labor (DOL) ensuring patient access to FMLA for participation in clinical trials

  November 18, 2024

   · 

  4 min read
• Press Releases

  Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

  November 18, 2024

   · 

  8 min read
• Press Releases

  Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024

  November 18, 2024

   · 

  7 min read
• Press Releases

  Surprising Study Finds No Link Between Rheumatoid Arthritis and Transfusion Risk After Knee Replacement

  November 18, 2024

   · 

  5 min read
• Press Releases

  SurgiBox Announces Strategic Partnership with Accord International to Expand into Japanese Market

  November 18, 2024

   · 

  2 min read
• Press Releases

  Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

  November 18, 2024

   · 

  3 min read
• Press Releases

  REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

  November 18, 2024

   · 

  15 min read
• Press Releases

  Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer

  November 18, 2024

   · 

  2 min read
• Press Releases

  Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

  November 18, 2024

   · 

  17 min read
• Press Releases

  NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with Charcot-Marie-Tooth Disease Type 1 and 2

  November 18, 2024

   · 

  5 min read